|
YALE COMPREHENSIVE CANCER CENTER
|
2P30CA016359-29
|
$1,871,000
|
$187,100
|
EDELSON, RICHARD
|
YALE UNIVERSITY
|
|
Xenobiotic-Metabolizing Enzymes
|
Z01 BC 005562
|
$318,876
|
$79,719
|
Gonzalez, Frank
|
CCR (NCI)
|
|
Xenobiotic Receptors
|
Z01 BC 005708
|
$531,461
|
$132,865
|
Gonzalez, Frank
|
CCR (NCI)
|
|
Wwox as a Critical Signal Mediator in Breast Cancer
|
5R01CA120516-02
|
$146,515
|
$146,515
|
HUEBNER, KAY
|
OHIO STATE UNIVERSITY
|
|
WUMC-Cancer and Leukemia Group B
|
5U10CA077440-10
|
$334,381
|
$163,847
|
BARTLETT, NANCY
|
WASHINGTON UNIVERSITY
|
|
Wound Response Genes in Cancer Progression
|
1R01CA118750-01A2
|
$300,024
|
$300,024
|
CHANG, HOWARD
|
STANFORD UNIVERSITY
|
|
Women's Health Study: Continued Follow-up
|
5R01CA047988-17
|
$1,666,176
|
$333,235
|
BURING, JULIE
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
WKy Rat Genetic Model for Breast Cancer Susceptibility
|
5R01CA077494-10
|
$306,962
|
$306,962
|
GOULD, MICHAEL
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Web-based Family History Screening for Hereditary Breast Cancer Risk
|
1R21CA127837-01
|
$185,400
|
$185,400
|
ACHESON, LOUISE
|
CASE WESTERN RESERVE UNIVERSITY
|
|
Washington University Small Animal Imaging Resource
|
5U24CA083060-09
|
$645,635
|
$225,972
|
ACKERMAN, JOSEPH
|
WASHINGTON UNIVERSITY
|
|
Washington University Molecular Imaging Center
|
2P50CA094056-07
|
$2,000,000
|
$660,000
|
PIWNICA-WORMS, David
|
WASHINGTON UNIVERSITY
|
|
Washington University Molecular Imaging Center
|
5P50CA094056-06
|
$363,851
|
$120,071
|
PIWNICA-WORMS, David
|
WASHINGTON UNIVERSITY
|
|
Vitamin D and Mammographic Density
|
5R03CA121360-02
|
$84,963
|
$84,963
|
TAMIMI, RULLA
|
BRIGHAM AND WOMEN'S HOSPITAL
|
|
VITAMIN D AND MAMMARY GLAND
|
3R01CA069700-13S1
|
$44,162
|
$44,162
|
Welsh, JoEllen
|
UNIVERSITY OF NOTRE DAME
|
|
VITAMIN D AND MAMMARY GLAND
|
5R01CA069700-13
|
$272,009
|
$272,009
|
WELSH, JOELLEN
|
UNIVERSITY OF NOTRE DAME
|
|
Virginia Mason Community Clinical Oncology Program
|
3U10CA035192-24S1
|
$80,000
|
$30,400
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Virginia Mason Community Clinical Oncology Program
|
5U10CA035192-24
|
$391,000
|
$148,580
|
Vuky, Jacqueline
|
BENAROYA RESEARCH INST AT VIRGINIA MASON
|
|
Viral Vectors in Tumors: Effects of Taxol and Radiation
|
5R01CA098706-05
|
$268,835
|
$268,835
|
BOUCHER, YVES
|
MASSACHUSETTS GENERAL HOSPITAL
|
|
Vermont Breast Cancer Surveillance System
|
5U01CA070013-13
|
$503,203
|
$503,203
|
GELLER, BERTA
|
UNIVERSITY OF VERMONT & ST AGRIC COLLEGE
|
|
VEGI-192 As An Anticancer Therapeutic Agent
|
5R01CA113875-02
|
$228,476
|
$57,119
|
LI, LUYUAN
|
UNIVERSITY OF PITTSBURGH AT PITTSBURGH
|
|
VEGF-based Targeted Imaging of Tumor Vasculature
|
2R44CA113080-02A2
|
$545,177
|
$545,177
|
Backer, Joseph
|
SIBTECH, INC.
|
|
VEGF mRNA Expression Mechanisms in Hypoxia
|
2R01CA064436-11A2
|
$271,728
|
$271,728
|
CLAFFEY, KEVIN
|
UNIVERSITY OF CONNECTICUT SCH OF MED/DNT
|
|
VCU Minority-Based CCOP
|
3U10CA052784-17S1
|
$100,000
|
$42,000
|
ROBERTS, JOHN
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
VCU Minority-Based CCOP
|
5U10CA052784-17
|
$527,332
|
$221,479
|
ROBERTS, JOHN
|
VIRGINIA COMMONWEALTH UNIVERSITY
|
|
Validating Area-Level Behavioral Profiles for Cancer Disparities Research
|
1R21CA124921-01A1
|
$196,800
|
$49,200
|
Klassen, Ann
|
JOHNS HOPKINS UNIVERSITY
|
|
Vaccine Clinical Trials
|
Z01 BC 010662
|
$666,536
|
$66,654
|
Arlen, Philip
|
CCR (NCI)
|
|
Vaccine Clinical Trials
|
Z01 BC 010666
|
$666,536
|
$66,654
|
Gulley, James
|
CCR (NCI)
|
|
UWCCC National Cooperative Drug Discovery Group for Can*
|
5U19CA113297-03
|
$1,052,474
|
$263,119
|
SHEN, BEN
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
2P30CA014520-34
|
$4,748,000
|
$997,080
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-34S1
|
$56,723
|
$11,912
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UW Comprehensive Cancer Center Support
|
3P30CA014520-34S2
|
$239,556
|
$50,307
|
WILDING, GEORGE
|
UNIVERSITY OF WISCONSIN MADISON
|
|
UTMDACC SPORE in Breast Cancer
|
3P50CA116199-03S1
|
$398,581
|
$398,581
|
HORTOBAGYI, GABRIEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
UTMDACC SPORE in Breast Cancer
|
5P50CA116199-03
|
$2,180,817
|
$2,180,817
|
HORTOBAGYI, GABRIEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
UTMB Center for Population Health and Health Disparities
|
5P50CA105631-05
|
$1,622,797
|
$210,964
|
GOODWIN, JAMES
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
|
Utah Breast Cancer Family Registry
|
5U01CA069446-13
|
$188,044
|
$188,044
|
BUYS, SAUNDRA
|
UNIVERSITY OF UTAH
|
|
UT Southwestern Small Animal Imaging Resource
|
1U24CA126608-01
|
$451,375
|
$90,275
|
MASON, RALPH
|
UNIVERSITY OF TEXAS SW MED CTR/DALLAS
|
|
UT M.D. Anderson Cancer Center
|
2U10CA045809-19
|
$1,362,206
|
$163,465
|
FISCH, MICHAEL
|
UNIVERSITY OF TEXAS MD ANDERSON CAN CTR
|
|
Using the UWBCS to Assess Racial Disparities in Breast Cancer Incidence & Surviva
|
1R03CA130727-01
|
$69,740
|
$69,740
|
Alagoz, Oguzhan
|
UNIVERSITY OF WISCONSIN MADISON
|
|
Using Physiological Age to Predict Chemotherapy Toxicity
|
1R01CA124924-01
|
$611,423
|
$611,423
|
MANDELBLATT, JEANNE
|
GEORGETOWN UNIVERSITY
|
|
Use of Cystatin C to Combat TGF-Beta Tumorigenesis
|
7R01CA114039-03
|
$255,996
|
$255,996
|
SCHIEMANN, WILLIAM
|
UNIVERSITY OF COLORADO DENVER/HSC AURORA
|
|
Use of Claims Data to Study Quality of Cancer Care
|
5R01CA104949-04
|
$161,072
|
$80,536
|
GOODWIN, JAMES
|
UNIVERSITY OF TEXAS MEDICAL BR GALVESTON
|
|
USC/NORRIS COMPREHENSIVE CANCER CENTER (CORE) SUPPORT
|
5P30CA014089-32
|
$6,578,401
|
$1,118,328
|
JONES, PETER
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
|
Urokinase Receptor-initiated Cell-signaling
|
2R01CA094900-07
|
$268,676
|
$268,676
|
GONIAS, STEVEN
|
UNIVERSITY OF CALIFORNIA SAN DIEGO
|
|
Urban Latino African American Cancer Disparities Project
|
5U56CA105389-05
|
$697,398
|
$261,524
|
Steinberg, Michael
|
DANIEL FREEMAN MEMORIAL HOSPITAL
|
|
Uptake of Vitamin A and Breast Cancer
|
1R03CA128091-01
|
$75,000
|
$75,000
|
ROWLING, MATTHEW
|
UNIVERSITY OF NOTRE DAME
|
|
UPSTATE CAROLINA COMMUNITY CLINICAL ONCOLOGY PROGRAM
|
2U10CA035119-23
|
$1,740,827
|
$644,106
|
BEARDEN, JAMES
|
SPARTANBURG REGIONAL MEDICAL CENTER
|
|
UPMC McKeesport/ROCOG Radiation Oncology Minorities Out*
|
3U56CA105486-05S1
|
$110,772
|
$27,693
|
HERON, DWIGHT
|
UPMC MC KEESPORT
|
|
UPMC McKeesport/ROCOG Radiation Oncology Minorities Out*
|
5U56CA105486-05
|
$794,122
|
$198,531
|
HERON, DWIGHT
|
UPMC MC KEESPORT
|
|
Unusual Regulation of the NF-kappaB/IKK Pathway by Ras
|
5R01CA073756-09
|
$249,182
|
$124,591
|
BALDWIN JR, ALBERT
|
UNIVERSITY OF NORTH CAROLINA CHAPEL HILL
|
|
UNRESOLVED PUBLIC HEALTH ISSUES RELATED TO HT AND CANCER
|
5P01CA017054-29
|
$2,094,891
|
$691,314
|
HENDERSON, BRIAN
|
UNIVERSITY OF SOUTHERN CALIFORNIA
|
Total relevant funding to Breast for this search: $572,360,688
|